Accelerated dual biomarker rule-out strategy safely reduces hospital stay in patients with chest pain
Denmark: The AROMI trial revealed the combination of prehospital copeptin and the first in-hospital high-sensitivity troponin T (hs-cTnT) could safely reduce the length of hospital stay compared to a...